Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding
Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Updated on: August 14,2024
0
0
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding
Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Updated on:August 14,2024
0
0
